Page last updated: 2024-08-25

ubenimex and HIV

ubenimex has been researched along with HIV in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borkowsky, W; Bourinbaiar, AS; Krasinski, K; Lee-Huang, S1
Brown, R; Conway, B; Izaguirre, CA; Proulx, P; Pulido-Cejudo, G1

Other Studies

2 other study(ies) available for ubenimex and HIV

ArticleYear
Inhibitory effect of the oral immune response modifier, bestatin, on cell-mediated and cell-free HIV infection in vitro.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 1994, Volume: 48, Issue:2

    Topics: Anti-Bacterial Agents; CD4-Positive T-Lymphocytes; Cell Division; Cell-Free System; Dextran Sulfate; HIV; HIV Infections; Immunity, Cellular; Immunologic Factors; In Vitro Techniques; Leucine; Virus Replication; Zidovudine

1994
Bestatin-mediated inhibition of leucine aminopeptidase may hinder HIV infection.
    Antiviral research, 1997, Volume: 36, Issue:3

    Topics: Anti-HIV Agents; Cytopathogenic Effect, Viral; HIV; HIV Core Protein p24; HIV Infections; Humans; Leucine; Leucyl Aminopeptidase; Protease Inhibitors; Protein Kinase C; Tumor Cells, Cultured

1997